199 related articles for article (PubMed ID: 37515143)
21. c-Met
Benkhoucha M; Tran NL; Senoner I; Breville G; Fritah H; Migliorini D; Dutoit V; Lalive PH
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137344
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Microtubule-Network Rescues CTL Killing Efficiency in Dense 3D Matrices.
Zhao R; Zhou X; Khan ES; Alansary D; Friedmann KS; Yang W; Schwarz EC; Del Campo A; Hoth M; Qu B
Front Immunol; 2021; 12():729820. PubMed ID: 34484240
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic T cells swarm by homotypic chemokine signalling.
Galeano Niño JL; Pageon SV; Tay SS; Colakoglu F; Kempe D; Hywood J; Mazalo JK; Cremasco J; Govendir MA; Dagley LF; Hsu K; Rizzetto S; Zieba J; Rice G; Prior V; O'Neill GM; Williams RJ; Nisbet DR; Kramer B; Webb AI; Luciani F; Read MN; Biro M
Elife; 2020 Oct; 9():. PubMed ID: 33046212
[TBL] [Abstract][Full Text] [Related]
24. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
Gadhamsetty S; Coorens T; de Boer RJ
J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic T Lymphocyte Activation Signals Modulate Cytoskeletal Dynamics and Mechanical Force Generation.
Pathni A; Özçelikkale A; Rey-Suarez I; Li L; Davis S; Rogers N; Xiao Z; Upadhyaya A
Front Immunol; 2022; 13():779888. PubMed ID: 35371019
[TBL] [Abstract][Full Text] [Related]
26. Defects in the acquisition of tumor-killing capability of CD8+ cytotoxic T cells in streptozotocin-induced diabetic mice.
Chen SC; Su YC; Lu YT; Ko PC; Chang PY; Lin HJ; Ho HN; Lai YP
PLoS One; 2014; 9(11):e109961. PubMed ID: 25390652
[TBL] [Abstract][Full Text] [Related]
27. High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function.
Foley MH; Forcier T; McAndrew E; Gonzalez M; Chen H; Juelg B; Walker BD; Irvine DJ
PLoS One; 2014; 9(2):e87873. PubMed ID: 24551068
[TBL] [Abstract][Full Text] [Related]
28. Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities.
Garcia V; Richter K; Graw F; Oxenius A; Regoes RR
PLoS Comput Biol; 2015 May; 11(5):e1004178. PubMed ID: 25933039
[TBL] [Abstract][Full Text] [Related]
29. Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver.
Liu L; Dai B; Li R; Liu Z; Zhang Z
Theranostics; 2021; 11(1):194-208. PubMed ID: 33391470
[TBL] [Abstract][Full Text] [Related]
30. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo.
Klein TW; Kawakami Y; Newton C; Friedman H
J Toxicol Environ Health; 1991 Apr; 32(4):465-77. PubMed ID: 1850002
[TBL] [Abstract][Full Text] [Related]
31. Generation of melanoma-specific cytotoxic T lymphocytes for allogeneic immunotherapy.
Nolte A; Scheffold C; Slotty J; Huenefeld C; Schultze JL; Grabbe S; Berdel WE; Kienast J
J Immunother; 2003; 26(3):257-69. PubMed ID: 12806279
[TBL] [Abstract][Full Text] [Related]
32. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
[TBL] [Abstract][Full Text] [Related]
33. MUC1-specific cytotoxic T lymphocytes eradicate tumors when adoptively transferred in vivo.
Mukherjee P; Ginardi AR; Tinder TL; Sterner CJ; Gendler SJ
Clin Cancer Res; 2001 Mar; 7(3 Suppl):848s-855s. PubMed ID: 11300482
[TBL] [Abstract][Full Text] [Related]
34. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
Sabzevari H; Reisfeld RA
Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683
[TBL] [Abstract][Full Text] [Related]
35. A general functional response of cytotoxic T lymphocyte-mediated killing of target cells.
Gadhamsetty S; Marée AF; Beltman JB; de Boer RJ
Biophys J; 2014 Apr; 106(8):1780-91. PubMed ID: 24739177
[TBL] [Abstract][Full Text] [Related]
36. Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes.
Alatrash G; Qiao N; Zhang M; Zope M; Perakis AA; Sukhumalchandra P; Philips AV; Garber HR; Kerros C; St John LS; Khouri MR; Khong H; Clise-Dwyer K; Miller LP; Wolpe S; Overwijk WW; Molldrem JJ; Ma Q; Shpall EJ; Mittendorf EA
Clin Cancer Res; 2019 Apr; 25(8):2610-2620. PubMed ID: 30647079
[TBL] [Abstract][Full Text] [Related]
37. Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.
Li A; Wu Y; Linnoila J; Pulli B; Wang C; Zeller M; Ali M; Lewandrowski GK; Li J; Tricot B; Keliher E; Wojtkiewicz GR; Fulci G; Feng X; Tannous BA; Yao Z; Chen JW
Cancer Immunol Immunother; 2016 Dec; 65(12):1545-1554. PubMed ID: 27722909
[TBL] [Abstract][Full Text] [Related]
38. In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2.
Berencsi K; Rani P; Zhang T; Gross L; Mastrangelo M; Meropol NJ; Herlyn D; Somasundaram R
J Transl Med; 2011 Mar; 9():33. PubMed ID: 21450101
[TBL] [Abstract][Full Text] [Related]
39. In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.
Halle S; Keyser KA; Stahl FR; Busche A; Marquardt A; Zheng X; Galla M; Heissmeyer V; Heller K; Boelter J; Wagner K; Bischoff Y; Martens R; Braun A; Werth K; Uvarovskii A; Kempf H; Meyer-Hermann M; Arens R; Kremer M; Sutter G; Messerle M; Förster R
Immunity; 2016 Feb; 44(2):233-45. PubMed ID: 26872694
[TBL] [Abstract][Full Text] [Related]
40. Rapid deletion and inactivation of CTLs upon recognition of a number of target cells over a critical threshold.
Prato S; Zhan Y; Mintern JD; Villadangos JA
J Immunol; 2013 Oct; 191(7):3534-44. PubMed ID: 24018271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
